Global Intranasal Drug Delivery Market Report 2019: Analysis, Trends, and Forecasts 2016-2024 – Focus on Allergic Infections, Analgesics, Osteoporosis, Vaccinations – ResearchAndMarkets.comPosted by On


DUBLIN–()–The “Intranasal Drug Delivery – Market Analysis, Trends, and Forecasts” report has been added to ResearchAndMarkets.com’s offering.

Annual estimates and forecasts are provided for the period 2016 through 2024. Also, a five-year historic analysis is provided for this market. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs.

This report analyzes the US Market for Intranasal Drug Delivery in US$ Million by the following Therapeutic Areas:

  • Allergic Infections
  • Analgesics
  • Osteoporosis
  • Vaccinations

The report profiles 64 companies including many key and niche players such as:

  • Aegis Therapeutics LLC (USA)
  • AptarGroup, Inc. (USA)
  • AstraZeneca Plc. (UK)
  • MedImmune, Inc. (USA)
  • Becton Dickinson and Company (USA)
  • GlaxoSmithKline Plc. (UK)
  • Johnson & Johnson Inc. (USA)
  • Marina Biotech, Inc. (USA)
  • Merck & Co., Inc. (USA)
  • Nemera (France)
  • Novartis AG (Switzerland)
  • OptiNose US Inc. (USA)
  • Pfizer, Inc. (USA)
  • Valeant Pharmaceuticals International, Inc. (Canada)

Key Topics Covered:

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability and Reporting Limitations

Disclaimers

Data Interpretation & Reporting Level

Quantitative Techniques & Analytics

Product Definition and Scope of Study

II. A US MARKET REPORT

1. INDUSTRY OVERVIEW

A Prelude

Intranasal Cavity: An Attractive Drug Delivery Route to Cross the Blood Brain Barrier

Factors Inhibiting Nose-to-Brain Transportation of Drugs

Drug’s Physico-Chemical Properties

Drug Dose, Concentration & Volume Administration

Mucociliary Clearance

Existence of Enzymatic Activity

Animal Species: Variations in Nasal Mucosa

Overcoming Barriers to Nose-to-Brain Delivery of Drugs

Prodrug Technique

Innovative Formulation

Use of Enzyme Inhibitors & Absorption Enhancers

Bioavailability: An Important Facet of Intranasal Drug Delivery

Chemical Modification

Transient Modification & Limited Enzymatic Activity

Bioavailability of Large Molecules

Bio-Adhesive Polymers: Useful in Increasing Drug Absorption

Outlook

Nasal Drug Delivery Devices & Equipment

Preservative Free Systems (PFS)

Traditional Vs. Advanced Intranasal Drug Formulation Types

Type of Nasal Delivery Vehicles with Select Therapeutic Agents and Area of Application

2. MARKET DRIVERS, TRENDS & ISSUES

Burgeoning Geriatric Populace Spurs Growing Demand for Intranasal Drug Therapies

Nasal Drug Delivery Offers New Opportunities for Drug Developers as Patent Cliffs Usher in Dusk of Blockbuster Era

Pharmaceutical and Medical Device Companies Vying to Develop New Intranasal Therapeutics for Allergic Rhinitis Patients

FDA Approved Intranasal Corticosteroids (INAC) and Intranasal Antihistamines (INAH) for Treating Allergic Rhinitis S

FDA Approved Nasal Spray Medication Types (excluding INAC & INAH) for Allergic Rhinitis Treatment

FDA Approved Intranasal Corticosteroids (INAC) and Intranasal Antihistamines (INAH) for Treating Allergic Rhinitis

FDA Approved Nasal Spray Medication Types (excluding INAC & INAH) for Allergic Rhinitis Treatment

Intranasal Corticosteroids

A Potential Treatment for Debilitating Chronic Rhinosinusitis Disease

Select Intranasal Corticosteroid Brands for Adult and Pediatric Usage

Self-Administration of Drugs Brings Intranasal Drug Delivery into the…

Original Author Link click here to read complete story.. (c)2018 Business Wire, Inc., All rights reserved.

Business

AllergicAnalgesicsAnalysisdeliverydrugFocusforecastsGlobalInfectionsIntranasalmarketOsteoporosisreportResearchAndMarketscomTrendsVaccinations

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.